Monogram Orthopedics (2023)
About this raise
Monogram Orthopedics, with a valuation of $155 million, is raising funds on DealMaker Securities. The company is developing a product solution architecture to allow the personalization of orthopedic implants. Monogram Orthopaedics uses 3D printing and robotics through automated digital image analysis algorithms. The Monogram Knee System has won FDA approval and is solving real problems by revolutionizing joint replacement technology. Dr. Douglas Unis founded Monogram Orthopaedics in 2016. The current crowdfunding campaign has a minimum target of $100,000 and a maximum target of $5,000,000. The campaign proceeds will be used for research and development.
Investment Overview
Invested : $4,599,145
Deal Terms
Total Commitments
- Platform
- DealMaker Securities
- Start Date
- 07/15/2022
- Close Date
- 03/16/2023
$100,000
$5,000,000
$500
Equity - Preferred
Growth Stage
RegCF
$10.01
$155,000,000
Company & Team
Company
- Year Founded
- 2016
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B2C
- Margin
- Low
- Capital Intensity
- High
Financials
-
Revenue
- $628,246
- Monthly Burn
- $984,581
-
Runway
- 5.6 months
- Gross Margin
- 27%
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Analyst Report
Higher precision and faster surgeries. That’s the name of the game with Monogram.
At first glance, this may seem too futuristic (and borderline impossible).
I’m here to tell you that Monogram has nearly done it. The company is conducting live surgical demonstrations of its robot for the orthopedic community and is gearing up for FDA submission.
Once the company’s robot is approved by the FDA, Monogram will launch its first-generation knee offering with generic implants. Once this has been successfully rolled out to hospitals, the company will release its second generation of implants: 3D-printed implants that closely match a patient's anatomy and stand to disrupt this space in a major way.
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $40,348,853
- Grants
- $256,000
- VC Backed?
- Yes
| Offering Name | Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|---|
| Monogram Orthopedics | 05/23/2023 | DealMaker Securities | $246,000,000 | $15,958,364 | Equity - Common | Funded | RegA+ |
| Monogram Orthopedics | 04/28/2023 | Republic | $246,000,000 | $232,275 | Equity - Common | Funded | RegA+ |
| Monogram Orthopedics | 03/16/2023 | DealMaker Securities | $155,000,000 | $4,599,145 | Equity - Preferred | Funded | RegCF |
| Monogram Orthopaedics | 02/18/2022 | StartEngine | $89,000,000 | $23,648,853 | Equity - Preferred | Funded | RegA+ |
| Monogram Orthopaedics | 01/16/2021 | StartEngine | $89,900,000 | $2,965,501 | Equity - Preferred | Funded | Test the Waters / RegA+ |
| Monogram Orthopaedics | 03/31/2020 | SeedInvest | $21,250,000 | $14,588,668 | Equity - Preferred | Funded | RegA+ |
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.